ASSIGNMENT

Clementi Ltd. has supported pharmaceutical and emerging biotechnology companies since 1991. The firm guides sponsors through regulatory strategy, FDA meetings and submissions for advanced therapies, including tissue-based products, peptides, large molecules, biologics and drug-device combinations. An in-house submissions group handles the filing work. Clementi reports more than 1,000 FDA submissions in recent years and more than 100 INDs across therapeutic areas.

The site has to make that range legible. A visitor should see how a development program fits together, what Clementi does inside it and who is on the team.

A + L Development designed and programmed regulatoryaffairs.com as a responsive single-page layout with animated and interactive elements. The hero rotates through the firm’s positions, including model-informed drug development, real-world evidence and novel preclinical models. An illustrated overview, “Where Every Piece Has a Purpose,” connects eCTD and IND work, CMC, toxicology, clinical protocol, document management, FDA meetings, GLP and monitoring audits. Service cards then cover FDA submissions, document management, CMC development and advanced therapies. The page closes with the team and a consultation form. The same structure holds on desktop, tablet and phone.